Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) reached a new 52-week high during mid-day trading on Friday . The company traded as high as C$0.11 and last traded at C$0.11, with a volume of 641138 shares traded. The stock had previously closed at C$0.09.
Voyageur Pharmaceuticals Price Performance
The company has a market capitalization of C$14.64 million, a PE ratio of -10.50 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm’s 50-day moving average is C$0.07 and its 200-day moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Golden Cross Stocks: Pattern, Examples and Charts
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What is Forex and How Does it Work?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Trading Stocks: RSI and Why it’s Useful
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
